Treatment outcome in ocular adnexal extranodal marginal zone B-cell lymphoma (EMZL) patients according to the IgG4-positive plasma cell infiltration.

*Fisher’s exact test.†Mann-Whitney U test.IgG4-positive group, ocular adenexal EMZL with IgG4:IgG cell ratio > 40%, and IgG4-positive plasma cells ≥ 50 / HPF; IgG4-negative group, ocular adenexal EMZL with IgG4-positive plasma cells CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease.Treatment outcome in ocular adnexal extranodal marginal zone B-cell lymphoma (EMZL) patients according to the IgG4-positive plasma cell infiltration.*费希尔精确检验（Fisher’s exact test）；†曼-惠特尼U检验（Mann-Whitney U test）。IgG4阳性组：指IgG4与IgG细胞比值＞40%、且IgG4阳性浆细胞≥50个/高倍视野（HPF）的眼附件结外边缘区B细胞淋巴瘤（EMZL）患者；IgG4阴性组：指伴IgG4阳性浆细胞的眼附件结外边缘区B细胞淋巴瘤（EMZL）患者。完全缓解（CR, complete response）、疾病进展（PD, progressive disease）、部分缓解（PR, partial response）、疾病稳定（SD, stable disease）为本次研究的疗效评价术语。基于IgG4阳性浆细胞浸润情况的眼附件结外边缘区B细胞淋巴瘤（EMZL）患者的治疗结局。